EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis

Laura Burney Ellis, Jack Tighe, Sarah J Bowden, Konstantinos S Kechagias, Maria Paraskevaidi, Akanksha Garg, Evangelos Paraskevaidis, Marc Arbyn, Areti Angeliki Veroniki, Ilkka Kalliala, James M Flanagan, Maria Kyrgiou

European Journal of Cancer · 2026

DOI: 10.1016/j.ejca.2026.116823 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift European Journal of Cancer, 2026. Verfasst von Laura Burney Ellis und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Metabolism, Digestion and Reproduction / Surgery and Cancer, Imperial College London, London W12 0NN, United Kingdom; Imperial College …. Hauptthemen laut MEDLINE: Uterine Cervical Dysplasia, DNA Methylation, Uterine Cervical Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imperial Health Charity, European Commission, Wellbeing of Women.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Human papillomavirus (HPV)-based cervical screening offers stronger protection against cervical intraepithelial neoplasia (CIN) than screening with cytology. DNA methylation tests have been proposed as an alternative triage test to cytology, although there is currently no consensus on the most accurate gene or gene panels ("markers"). METHODS: We conducted a meta-analysis of accuracy of human and HPV methylation markers to detect CIN2 or worse (CIN2+), CIN3+, and cervical cancer (CRD42022299760). We systematically searched three databases to March 2025. We used a bivariate random-effects model to produce pooled sensitivity, specificity, diagnostic odds ratios (DORs), positive and negative likelihood ratios (LR+, LR-) for each marker at each available endpoint. Our primary analysis was in HPV+ women, and secondary analysis included all data regardless of HPV positivity. RESULTS: We included 51 studies exploring 13 methylation markers in 28,977 HPV+ women, and in total 125 studies assessing 32 markers in 49,242 women. For HPV+, the markers with the highest DORs were JAM3 (20.82 [95%CI 14.41-30.08]), C13ORF18 (19.50 [95%CI 11.65-32.65]), and PAX1 (17.13 [95%CI 9.20-31.89]). EPB41L3 had the lowest LR- (0.26 [95%CI 0.19-0.35]). In all women, SOX1 had the highest DOR (29.72 [95%CI 12.84-68.81]), although JAM3 and PAX1 maintained good accuracy (DORs 26.73 [95%CI 19.97-35.77] and 23.96 [95%CI 17.32-33.15]). CONCLUSION: Several methylation markers reported good sensitivity in the detection of CIN3+ whilst maintaining high specificity. These have potential to reduce unnecessary referrals to colposcopy. Methylation markers may permit efficient triage on self-samples which are inappropriate for cytology, although this requires further study ideally in screening cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical DysplasiaDNA MethylationUterine Cervical NeoplasmsBiomarkers, TumorEarly Detection of CancerHumansFemalePapillomavirus InfectionsHuman Papillomavirus VirusesSensitivity and Specificity

Stichwörter der Autor:innen

‘Cervical intraepithelial neoplasia’‘Cervical screening’‘DNA methylation’‘Diagnostic testing’‘Epigenetics’‘Human papillomavirus’‘Meta-analysis’

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Metabolism, Digestion and Reproduction / Surgery and Cancer, Imperial College London, London W12 0NN, United Kingdom; Imperial College Healthcare NHS Trust, London W12 0HS, United Kingdom.
  • Imperial College Healthcare NHS Trust, London W12 0HS, United Kingdom.
  • Department of Metabolism, Digestion and Reproduction / Surgery and Cancer, Imperial College London, London W12 0NN, United Kingdom.
  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, Yale University, New Haven, USA.
  • University of Ioannina, Ioannina, Greece.
  • Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, University Ghent, Ghent, Belgium; Unit of Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels, Belgium.

Förderung

  • Imperial Health Charity
  • European Commission
  • Wellbeing of Women
  • Sigrid Juséliuksen Säätiö
  • MSD
  • Wellcome Trust
  • Cancer Research UK
  • National Institute on Handicapped Research

Zitieren

APA

Ellis, L. B., Tighe, J., Bowden, S. J., Kechagias, K. S., Paraskevaidi, M., Garg, A., Paraskevaidis, E., Arbyn, M., Veroniki, A. A., Kalliala, I., Flanagan, J. M., & Kyrgiou, M. (2026). Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2026.116823

Vancouver

Ellis LB, Tighe J, Bowden SJ, Kechagias KS, Paraskevaidi M, Garg A, et al. Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis. European Journal of Cancer. 2026. doi:10.1016/j.ejca.2026.116823

BibTeX
@article{Ellis2026,
  author = {Ellis, Laura Burney and Tighe, Jack and Bowden, Sarah J and Kechagias, Konstantinos S and Paraskevaidi, Maria and Garg, Akanksha and Paraskevaidis, Evangelos and Arbyn, Marc and Veroniki, Areti Angeliki and Kalliala, Ilkka and Flanagan, James M and Kyrgiou, Maria},
  title = {Diagnostic testing accuracy of DNA methylation tests for detection of high-grade cervical intraepithelial neoplasia and cervical cancer: A systematic review and meta-analysis},
  journal = {European Journal of Cancer},
  year = {2026},
  doi = {10.1016/j.ejca.2026.116823}
}
Kostenlos starten →